ATLANTA, March 02, 2022 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announces that Rick Eiswirth, Alimera’s President and Chief Executive Officer, will present a corporate overview at the Q1 Investor Summit Conference, which is being held virtually on March 8 – 9, 2022.
Mr. Eiswirth will deliver his corporate presentation on Wednesday, March 9, 2022 at 8:45 AM ET.
Additionally, Mr. Eiswirth and Phil Jones, Alimera’s Chief Financial Officer, will be available for one-on-one investor meetings on Wednesday, March 9, 2022.
Click here to register: Q1 Investor Summit – INVESTOR REGISTRATION
About Alimera Sciences, Inc.
Alimera Sciences is a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer. For more information, please visit www.alimerasciences.com.
| For press inquiries: Jules Abraham for Alimera Sciences 917-885-7378 julesa@coreir.com |
For investor inquiries: Scott Gordon for Alimera Sciences scottg@coreir.com |
London, United Kingdom--(Newsfile Corp. - April 12, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or…
MINNEAPOLIS, MN / ACCESSWIRE / April 12, 2024 / LIVIN Foundation, a Minnesota-based non-profit and…
- Synuclein-One Study plenary session on Monday, April 15 at 9:15 a.m. MT will report…
Red Light Holland Advances Psilocybin Research Collaboration with CCrest Labs and PharmAla BiotechLargest Shipment of…
Toronto, Ontario--(Newsfile Corp. - April 12, 2024) - Glow LifeTech Corp. (CSE: GLOW) (OTC Pink:…
Halifax, Nova Scotia--(Newsfile Corp. - April 12, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB:…